Krishna Surapaneni, MD
Ophthalmology · Houston, TXNPI 1215321427
Payments from drug & device makers
Across 170 payments — averaging $72.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- AbbVie$3K
- Carl Zeiss Meditec USA, Inc.$2K
- Rxsight Inc$1K
- Tarsus Pharmaceuticals, Inc.$746
- Bausch & Lomb Americas Inc.$378
- plus $2K from 15 others
What the payments were for
- Consulting fees$1,40011%
- Food & beverage$10,99389%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 52 | $3,543 |
| AbbVie(2 entities) | 22 | $2,688 |
| Carl Zeiss Meditec USA, Inc. | 21 | $1,569 |
| Rxsight Inc | 19 | $1,215 |
| Tarsus Pharmaceuticals, Inc. | 12 | $746 |
| Bausch & Lomb Americas Inc. | 4 | $378 |
| Glaukos Corporation | 6 | $365 |
| Rayner Intraocular Lenses Limited | 2 | $300 |
| Lensar, Inc. | 3 | $263 |
| Aerie Pharmaceuticals, Inc. | 3 | $240 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $234 |
| Sight Sciences, Inc. | 6 | $167 |
| Dompe US, Inc. | 2 | $147 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $105 |
| Carl Zeiss Meditec, Inc. | 2 | $95 |
| Coopervision Inc. | 2 | $88 |
| Ivantis, Inc | 1 | $70 |
| NEW World Medical,inc. | 1 | $60 |
| Biotissue Holdings Inc. | 3 | $51 |
| Harrow Eye, LLC | 2 | $40 |
| Lombart Brothers, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DURYSTA$1,650
- XEN GLAUCOMA TREATMENT SYSTEM$1,400
- Wavelight Refractive Suite$862
- RXSIGHT CONTACT LENS$700
- RXSIGHT INJECTOR CARTRIDGE$700
- RXSIGHT INJECTOR HANDPIECE$700
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$700
- LIGHT ADJUSTABLE LENS (LAL)$571
- RayOne EMV$300
- RayOne Spheric$300
- RayOne Aspheric$300
- Wavelight Plus$300
- Clareon$268
- ARTEVO 800$253
- Rhopressa$228
- Rocklatan$228
- OZURDEX$226
- WaveLight EX500 Excimer Laser$205
- RAYNER CATARACT SET 1$188
- CIRRUS HD-OCT$182
How this compares
$12,393 in reported general payments places this provider in the 80th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 34 | $1,652 |
| MoxifloxacinMoxifloxacin Hcl | 31 | $1,050 |
| Timolol Maleate | 11 | $94 |
| Latanoprost | 25 | $82 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Houston
- David BrownHouston$51.7M
- John MichelettiHouston$3.3M
- Michael CaplanHouston$1.4M
- Shaheen KavoussiHouston$1.3M
- Kevin JongHouston$1.2M
- Stephen SladeHouston$1.2M
- Rosa TangHouston$1.1M
- Zaina Al-MohtasebHouston$1.1M
- Fiaz ZamanHouston$1M
- Stephen PflugfelderHouston$788K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.